drugset / Trial / NCT01765842
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
Phase 3
Terminated
9 enrolled
Fundación Pública Andaluza Progreso y Salud
Ministry of Health, Spain · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy Resistant to Conventional Treatments
Timeline
- Start
- 2012-11
- Primary completion
- 2014-11
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped (Enrollment): “The recruitment period has finished without reaching sample size”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | Intravenous |